Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Michael Kelner0
Date of Patent
July 2, 2024
0Patent Application Number
175087290
Date Filed
October 22, 2021
0Patent Citations
...
Patent Primary Examiner
Patent abstract
In an embodiment of the invention, a method of treating cancer includes screening to select a patient population that will respond to an Illudofulvene Analog composition based on the presence of one or more Transcription Coupled Repair (TCR) mutations, deletions or other events interfering with TCR biomarker expression in combination with upregulation of Myc and/or PTGR biomarker expression and treating the patient population with the Illudofulvene Analog composition.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
